Government of India plans to launch its own brand Jan Aushadhi

By: Pharma News | Views: 1705 | Date: 16-Mar-2015

The Government of India plans to launch its own brand of low cost generic medicines by July 1, 2015. The Jan Aushadhi medicines are expected to make a difference in the public healthcare system in the country as the central government plans to procure medicines in bulk from public as well as private drug manufacturing firms and rebrand them under the Jan Aushadhi brand. The medicines are expected to be retailed at a competitive price, expected to allow consumers to buy a cheaper yet quality product from the

Government of India plans to launch its own brand Jan Aushadhi generic drugs

The Government of India plans to launch its own brand of low cost generic medicines by July 1, 2015. The Jan Aushadhi medicines are expected to make a difference in the public healthcare system in the country as the central government plans to procure medicines in bulk from public as well as private drug manufacturing firms and rebrand them under the Jan Aushadhi brand. The medicines are expected to be retailed at a competitive price, expected to allow consumers to buy a cheaper yet quality product from the government.

The government has already identified 504 essential medicines, including antibiotics, painkillers, vitamins and medicines. It may be noted here that the government has largely identified drugs going by the sales of top 100 drugs and more medicines and medical devices will be included in the second phase.

The Bureau of Pharma Public Sector Undertakings of India (BPPI), the nodal agency under the department of pharmaceuticals (DoP) for implementing this project, has already floated the tender seeking application for supply of medicines for the programme. In the first phase, these drugs will be made available to 800 select chemists, mostly across Delhi. However, the government plans to expand the reach to most metros by the end of the year.

It is important to note here that the high usage of generics by the Indian population can be expected to send a strong message to developed and developing economies across the globe as India is one of the major player in the generic drugs industry across the globe.

The move will also play an important role in controlling the government expenditure on healthcare and increasing the usage of generic drugs in the Indian market.